Clinical Trial of Chemosensitivity Test

• Status: Completed
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the usefulness of chemosensitivity test in evaluating the appropriate adjuvant cancer chemotherapy after gastric surgery

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Japan Clinical Cancer Research Organization
• Collaborator: Kitasato University

Criteria

Inclusion Criteria:

• histologically proven gastric cancer

• PS (ECOG) 0 or 2

• D2 dissection, curability B or more

• surgical Stage IIIA and IIIB

• negative peritoneal cytology

• no previous radiotherapy, chemotherapy and hormone therapy

• possible peroral intake at 6 POW

• no severe surgical complication

• normal bone marrow, liver and renal function

• complete chemosensitivity test

• written informed consent

Exclusion Criteria:

• multiple cancer

• contraindication for S-1

• history of drug allergy (grade 3)

• severe complication

• watery diarrhea

• pregnant

• scirrhous gastric cancer

• the other patients who was judged as inadequate for trial by doctor on duty